Abstract:OBJECTIVE:To explore the mechanism of nuclear factor-kappa B (NF-κB), phosphatidylinositol 3-kinase (PI3K)/protein kinase B(PKB/Akt) and mitogen-activated protein kinase (MAPK) signaling pathways after intervention of advanced glycosylation end products (AGEs) in peripheral blood mononuclear cells (PBMCs) and osteoblasts (OB) in rats, so as to provide certain experimental basis and theoretical basis for further research on the clinical treatment of periodontal tissue inflammation caused by diabetes mellitus. METHODS:AGEs were prepared, PBMCs and OB were isolated and cultured in vitro. CCK-8 was used to detect the cell viability intervened by different concentrations and time of AGEs. Western blot and qRT-PCR were used to detect the expression changes of genes related to NF-κB, PI3K/PKB and MAPK signaling pathways. RESULTS:OB and PBMCs were successfully isolated and cultured in vitro. The activity of PBMCs and OB cells was significantly correlated with the concentration, time and interaction of AGEs. With the increase of AGEs concentration and time, the activity of PBMCs and OB cells significantly decreased (P < 0.001). AGEs stimulation significantly increased the expression of NF-κB in PBMCs and the contents of tumor necrosis factor α(TNF-α), interleukin-1β(IL-1β) (P < 0.01). TNF-α, IL-1β levels were significantly reduced after inhibition of NF-κB pathway (P < 0.01). NF-κB p65, JNK, and p38 phosphorylated and non-phosphorylated proteins increased significantly after AGEs stimulation of OB (P < 0.05). The phosphorylated protein expression of IκB was significantly increased, while the expression of non-phosphorylated protein was decreased (P < 0.01).The expressions of NF-κB p65, JNK, and IκB were significantly increased at the mRNA levels, and the expressions of IκB mRNA were significantly decreased (P < 0.05). There was no difference in the expression of Akt in either phosphorylated or non-phosphorylated proteins or at the mRNA level (P>0.05). With the addition of MAPK signaling pathway inhibitors, the phosphorylation and non-phosphorylated protein expressions of NF-κB p65, p38 and JNK were significantly reduced, and the phosphorylated protein of IκB was significantly decreased and the non-phosphorylated protein was significantly increased compared with the group with AGEs alone (P < 0.05). The results of qRT-PCR showed that the expression of IκB increased significantly after the addition of the JNK pathway blocker (P < 0.05), and the expression of NF-κB p65, p38 and JNK decreased, but the difference was not significant (P>0.05). While NF-κB p65, p38 and JNK were significantly decreased and IκB was significantly increased in the AGEs group after the addition of the p38 pathway blocker (P < 0.05). At this time, there was still no significant change in the expression of Akt at the protein level and mRNA level (P>0.05). CONCLUSION:AGEs inhibit the proliferation of PBMCs and OB, and the NF-κB and MAPK pathways are likely involved in regulating this process, but not the PI3K/PKB pathway.

Effect of Advanced Glycosylation End Products on Level of Nitric Oxide and Activity of Nitric Oxide Synthase in Cultured Macrophages

The Role of RAGE, MAPK and NF-κB Pathway in the Advanced Glycation End-Products Induced HUVECs Dysfunction

AGEs Increased Migration and Inflammatory Responses of Adventitial Fibroblasts Via RAGE, MAPK and NF-κB Pathways

Role of Advanced Glycation End Products on Expression of Nampt in Macrophages

Effects of Advanced Glycation End Products on Activity and Expression of Nitric Oxide Synthase in Human Umbilical Vein Endothelial Cells and the Protective Effects of Metformin

Advanced Glycation End Products Increased Angiopoietin-1 Expression Via Oxidative Stress and NF-κB Pathways in Cultured NRK-49F Cells

Inhibition of Human Endothelial Cell Nitric Oxide Synthesis by Advanced Glycation End-Products but Not Glucose: Relevance to Diabetes.

Effect of Advanced Glycation End Products on the Content of Nitric Oxide and the Activity of Nitric Oxide Synthase in Rat Cavernosum

Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products.

Effects of Advanced Glycosylation End Products on the Biological Behavior of Neutrophils

AGEs and chronic subclinical inflammation in diabetes: disorders of immune system.

Advanced Glycation Endproducts Increase EPC Apoptosis and Decrease Nitric Oxide Release Via MAPK Pathways

Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells

Protein-bound AGEs Derived from Methylglyoxal Induce Pro-Inflammatory Response and Barrier Integrity Damage in Epithelial Cells by Disrupting the Retinol Metabolism

Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype Through Activating RAGE/NF-κB Pathway

The Effect of Advanced Glycation End Products on the Expression of Matrix Metalloproteinase Inducer and the Activity of Matrix Metalloproteinase-9 in Cultured Mouse Macrophage

Effect of Advanced Glycation End Products on Activity and Expression of Platelet Endothelial Nitric Oxide Synthase in the Normals

Astragalus Membranaceus Inhibits Inflammation Via Phospho-P38 Mitogen-Activated Protein Kinase (MAPK) and Nuclear Factor (Nf)-Κb Pathways in Advanced Glycation End Product-Stimulated Macrophages.

Mechanism of Advanced Glycation End Products Inhibiting the Proliferation of Peripheral Blood Mononuclear Cells and Osteoblasts in Rats

Effect of AGE and glucose on CXCL16 mRNA expression in THP-1 macrophages

Effect of Advanced Glycosylation End Products on Diacylglycerol Signaling Pathway in Cultured Rat Aortic Smooth Muscle Cells.